The University of the Sunshine Coast has formalised a global clinical trials collaboration to conduct potential world-first trials and contribute to breakthrough medical treatments and therapies.
Deputy Vice-Chancellor (Research and Innovation) Professor Ross Young said UniSC welcomed the opportunity to work alongside international medical experts and industry to address health challenges.
“This clinical trials partnership with the Queensland-based Translational Science Hub (TSH), involving global healthcare company Sanofi and the Queensland Government, is a significant development for the University,” he said.
TSH connects world-class researchers in Queensland with Sanofi scientists in France and the US, creating a global scientific community focused on mRNA technology and translational science.
“As the University with the state’s largest clinical trials network, UniSC is pleased to help people live well and live longer by contributing to cutting-edge medical solutions for a wide range of diseases and conditions,” Professor Young said.
“This collaboration also supports Queensland’s position as an emerging hub for biomedical innovation and demonstrates the strength of combining our expertise with international partners to advance global health care.”
One of the first studies undertaken by the TSH is a potential world-first mRNA vaccine to prevent chlamydia infection in humans.
UniSC Clinical Trials is conducting the investigational study, with trials now underway at sites in South Brisbane, Moreton Bay and Sunshine Coast.
“Our commitment to this vaccine is strong, given that chlamydia is a silent epidemic and a critical health challenge worldwide,” Professor Young said.
“Many infected people don’t have any symptoms, so it is vital to find a preventative strategy to ensure we have improved sexual health in our communities.”
Executive Director of Strategic Industry Development for the Department of State Development, Infrastructure and Planning, Denise Johnston, welcomed the world-first trial to Queensland.
“This is an incredible opportunity to contribute Queensland's expertise to an important cause,” Ms Johnston said.
“It’s an outstanding achievement for the University of Sunshine Coast. Our ongoing partnership with Sanofi and Queensland universities continues to yield great results for our state.
“It's innovation like this that helps keep Queensland's biomedical industry flourishing.”
Media enquiries: Please contact the Media Team media@usc.edu.au